These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Aerts F; De Brabander M; van den Bossche H; van Cutsem J; Borgers M Mykosen; 1980 Feb; 23(2):53-67. PubMed ID: 6247651 [No Abstract] [Full Text] [Related]
3. Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicans. Beggs WH Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):495-8. PubMed ID: 6294764 [TBL] [Abstract][Full Text] [Related]
4. Modified response to ketoconazole of Candida albicans from a treatment failure. Warnock DW; Johnson EM; Richardson MD; Vickers CF Lancet; 1983 Mar; 1(8325):642-3. PubMed ID: 6131314 [No Abstract] [Full Text] [Related]
5. Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species. Beggs WH J Antimicrob Chemother; 1983 Apr; 11(4):381-3. PubMed ID: 6304001 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole. Eng RH; Person A; Mangura C; Chmel H; Corrado M Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783 [TBL] [Abstract][Full Text] [Related]
7. Ketoconazole and the Actinomycetales. Martin MV Lancet; 1982 Apr; 1(8275):807. PubMed ID: 6121258 [No Abstract] [Full Text] [Related]
8. Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolates. Pfaller MA; Segal JJ; Krogstad DJ Antimicrob Agents Chemother; 1982 Nov; 22(5):917-9. PubMed ID: 6295271 [TBL] [Abstract][Full Text] [Related]
9. Imidazoles, ketoconazole, amphotericin B, and Candida guilliermondii. Wilson G; Peacock JE Ann Intern Med; 1985 Jun; 102(6):866. PubMed ID: 3994204 [No Abstract] [Full Text] [Related]
10. The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. Van Cutsem J; Borgers M; De Brabander M Mykosen; 1981 Oct; 24(10):596-602. PubMed ID: 6270550 [No Abstract] [Full Text] [Related]
11. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts. Beggs WH; Sarosi GA Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603 [TBL] [Abstract][Full Text] [Related]
12. In-vitro studies of a new oral azole antimycotic, BAY N 7133. Yamaguchi H; Hiratani T; Plempel M J Antimicrob Chemother; 1983 Feb; 11(2):135-49. PubMed ID: 6300015 [TBL] [Abstract][Full Text] [Related]
13. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. Odds FC; Milne LJ; Gentles JC; Ball EH J Antimicrob Chemother; 1980 Jan; 6(1):97-104. PubMed ID: 6244258 [No Abstract] [Full Text] [Related]
14. Combined activity of ketoconazole and sulphamethoxazole against Candida albicans. Beggs WH J Antimicrob Chemother; 1982 Dec; 10(6):539-41. PubMed ID: 6298174 [No Abstract] [Full Text] [Related]
16. Ketoconazole. Jones HE Arch Dermatol; 1982 Apr; 118(4):217-9. PubMed ID: 6279033 [No Abstract] [Full Text] [Related]
17. Effect of ketoconazole on the initial stages of germ tube formation by strains of Candida albicans. Johnson EM; Barnard ML; Richardson MD; Warnock DW Mykosen; 1982 Sep; 25(9):481-6. PubMed ID: 6292712 [No Abstract] [Full Text] [Related]
18. Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole. Hironaga M; Mochizuki T; Watanabe S Mycopathologia; 1982 Aug; 79(2):101-4. PubMed ID: 6290889 [No Abstract] [Full Text] [Related]
19. Effects of pH on the activity of ketoconazole against Candida albicans. Minagawa H; Kitaura K; Nakamizo N Antimicrob Agents Chemother; 1983 Jan; 23(1):105-7. PubMed ID: 6299178 [TBL] [Abstract][Full Text] [Related]
20. The effect of ketoconazole on steroidogenesis in cultured mouse adrenal cortex tumor cells. Kowal J Endocrinology; 1983 Apr; 112(4):1541-3. PubMed ID: 6299699 [No Abstract] [Full Text] [Related] [Next] [New Search]